TrialPath
Recruiting

Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study

NCT06656832 · University of Leipzig
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
See above.
Eligibility criteria
Inclusion Criteria: * Patients admitted to the participating study centres with acute decompensated heart failure (ADHF), defined as clinical signs and/or symptoms of heart failure * objective structural cardiac abnormalitites according to the ESC criteria. Exclusion Criteria: * Age \<18 years * pregnancy * any condition interfering with the informed consent process * patients placed in an institution by official or court order
Study design
Enrollment target: 1000 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2024-11-28
Estimated completion: 2028-12-31
Last updated: 2026-05-06
Interventions
Other: Heart Failure network care
Primary outcomes
  • Change in NT-proBNP plasma levels between baseline and 6 months visit (6 months)
Sponsor
University of Leipzig · other
Contacts & investigators
ContactRolf Wachter, MD · contact · rolf.wachter@medizin.uni-leipzig.de · +49-341-97-12650
ContactSophie Charlotte Schröder, MD · contact · sophiecharlotte.schroeder@medizin.uni-leipzig.de · +49-341-97-12650
All locations (1)
University Hospital LeipzigRecruiting
Leipzig, Germany
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study · TrialPath